Showing results (341-350 of 421) with videos related to

Sort By:
Pageof 43
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
Lancet (London, England)|February 16, 2021
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trialSumanta K Pal, Catherine Tangen, Ian M Thompson, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
NPJ Digital Medicine|March 23, 2025
Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learningZilong Bai, Mohamed Osman, Matthew Brendel, et al.
The Prostate|May 21, 2016
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trialHaitao Chen, Xu Liu, Charles B Brendler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Cancer Cell|August 17, 2013
Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancerPei-Yin Hsu, Hang-Kai Hsu, Xun Lan, et al.
Disease Markers|July 20, 2004
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancerWilliam E Grizzle, Bao-Ling L Adam, William L Bigbee, et al.
Pageof 43